Almeda-Valdes P, Velasco DVG, Campos OA, et al. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes. Eur J Endocrinol. 2019;180(2):99-107. doi:10.1530/EJE-18-0677Google ScholarPubMedDOI
Galinsky KJ, Reshef YA, Finucane HK, et al. Estimating cross-population genetic correlations of causal effect sizes. Genet Epidemiol. 2019;43(2):180-188. doi:10.1002/gepi.22173PubMedDOIGoogle Scholar
Dashti HS, Redline S, Saxena R. Polygenic risk score identifies associations between sleep duration and diseases determined from an electronic medical record biobank. Sleep. 2019;42(3). doi:10.1093/sleep/zsy247PubMedDOIGoogle Scholar
Emdin CA, Khera AV, Aragam K, et al. DNA Sequence Variation in Encoding the Activin Receptor-Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes. Diabetes. 2019;68(1):226-234. doi:10.2337/db18-0857PubMedGoogle ScholarDOI
Ma Y, Yang W, Song M, et al. Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br J Cancer. 2018;119(11):1436-1442. doi:10.1038/s41416-018-0314-4Google ScholarPubMedDOI
Guasch-Ferré M, Ruiz-Canela M, Li J, et al. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk. J Clin Endocrinol Metab. 2019;104(5):1508-1519. doi:10.1210/jc.2018-01000Google ScholarPubMedDOI
Strausz S, Havulinna AS, Tuomi T, et al. Obstructive sleep apnoea and the risk for coronary heart disease and type 2 diabetes: a longitudinal population-based study in Finland. BMJ Open. 2018;8(10):e022752. doi:10.1136/bmjopen-2018-022752PubMedDOIGoogle Scholar
Razquin C, Toledo E, Clish CB, et al. Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial. Diabetes Care. 2018;41(12):2617-2624. doi:10.2337/dc18-0840PubMedDOIGoogle Scholar
Hivert MF, Christophi CA, Jablonski KA, et al. Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2019;104(2):328-336. doi:10.1210/jc.2018-01416Google ScholarPubMedDOI
Zwakenberg SR, Remmelzwaal S, Beulens JWJ, et al. Circulating Phylloquinone Concentrations and Risk of Type 2 Diabetes: A Mendelian Randomization Study. Diabetes. 2019;68(1):220-225. doi:10.2337/db18-0543PubMedDOIGoogle Scholar